![Li Yan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Li Yan
Direttore Tecnico/Scientifico/R&S presso Brii Biosciences Ltd.
Posizioni attive di Li Yan
Società | Posizione | Inizio | Fine |
---|---|---|---|
Brii Biosciences Ltd.
![]() Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Li Yan
Precedenti posizioni note di Li Yan
Società | Posizione | Inizio | Fine |
---|---|---|---|
BRII BIOSCIENCES LIMITED | Direttore Tecnico/Scientifico/R&S | 02/04/2018 | 05/07/2023 |
GSK PLC | Corporate Officer/Principal | - | - |
Formazione di Li Yan
Peking University Health Science Center | Undergraduate Degree |
University of Kansas | Doctorate Degree |
Statistiche
Distribuzione geografica
Cina | 3 |
Stati Uniti | 3 |
Regno Unito | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRII BIOSCIENCES LIMITED | Commercial Services |
GSK PLC | Health Technology |
Aziende private | 1 |
---|---|
Brii Biosciences Ltd.
![]() Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Li Yan
- Esperienza